New SEC Form D filing

Georgiamune, Inc., 2026-08-17

A new SEC Form D private-offering notice from Gaithersburg, MD, a $131,852,011 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Georgiamune, Inc. site↗ Verified via SEC Form D

Clinical stage biotechnology company developing immunotherapies that reprogram immune signaling pathways to treat cancer and autoimmune diseases

New filing 2 days agoFiled to raise $131,852,011First money in 2026-07-16Raised so far $92,692,709HQ (as filed) Gaithersburg, MDSector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified georgiamune.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source